The impact of preformed donor-specific antibodies in living donor liver transplantation according to graft volume.

Ryoichi GotoMakoto ItoNorio KawamuraMasaaki WatanabeYoshikazu GanchikuToshiya KamiyamaTsuyoshi ShimamuraAkinobu Taketomi

Published in: Immunity, inflammation and disease (2022)

Patients with preformed DSAs exhibited worse graft outcomes in living donor liver transplantation. Higher DSA-MFI values and smaller graft size were associated with worse outcomes in LCT-positive patients. High-risk patients with preformed DSAs should be considered for appropriate graft selection and application of a desensitization protocol.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
randomized controlled trial
prognostic factors
metabolic syndrome
skeletal muscle
weight loss
patient reported